- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03403491
Study of Self-monitoring of Weight & Blood Pressure (Via patientMpower Platform) in Hemodialysis
Pilot-scale, Randomized Study Comparing Self-monitoring of Weight and Blood Pressure Via an Electronic Health Journal (patientMpower Platform) With Usual Care in Haemodialysis Patients
Pilot-scale study to assess the effect of self-monitoring using the patientMpower electronic health journal (pMp app) [+digital weighing scales & BP monitor] on outcomes in ambulatory haemodialysis patients. Design: prospective, open-label, random order, sham-controlled, two-period crossover comparison of the pMp app [+digital weighing scales & BP monitor] compared with a sham application (without weighing scales or BP monitor). Duration: 10 weeks (usual care run-in for 2 weeks followed by 2 x 4 observation periods).
Primary objective is to determine the frequency of use of the pMp app [+digital weighing scales & BP monitor] in patients randomized to that observation method. Additional objectives are to determine the effect of pMp app [+digital weighing scales & BP monitor] on proportion of haemodialysis sessions in which ultrafiltration rate is ≤ 10 mL/kg/h and in which interdialytic weight gain (IDWG) is ≤ 4% and effect of pMp on pre-dialysis weight and BP, medication adherence, compliance with daily recording (of fluid intake, weight, BP) and requirement for additional unscheduled dialysis.
An additional objective is to assess the acceptability and utility of the pMp app in helping hemodialysis patients and their healthcare professional caregivers manage their condition (assessed from both patient and healthcare professional perspective).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Pilot-scale, prospective, open-label, randomized, two-period, cross-over intervention study.
Each patient will be randomized to one of the two possible observation sequences:
Sequence 1: run-in (2 weeks): usual care followed by period 1 (4 weeks): patientMpower application (+digital weighing scales & BP monitor) followed by period 2 (4 weeks): sham application
OR
Sequence 2: run-in (2 weeks): followed by period 1 (4 weeks) sham application followed by period 2 (4 weeks): patientMpower application (+digital weighing scales & BP monitor)
The study will not make any other changes to the therapeutic interventions offered to the patients. Patients will follow their usual care and hemodialysis programme throughout the study.
Proposed sample size is approximately 50 patients.
Patients will be recruited through three haemodialysis facilities under the governance of Beaumont Hospital, a tertiary care centre for nephrology in Dublin, Ireland.
The study observational intervention is an electronic health journal, the patientMpower application (with a supplied digital weighing scales and BP monitor). This has been developed specifically for patients undergoing hemodialysis. The app is an electronic application downloaded to the patient's mobile phone or tablet device. The app is designed to allow the patient to report various parameters relevant to hemodialysis and record these on a regular basis, ideally daily. The information recorded by the patients will be stored in a secure cloud system and will be available to the patient through their phone or mobile device at all times. No personal health data are stored on the phone or mobile device itself.
Patient-reported measures (at a minimum) will include body weight (at least one reading /day), BP and compliance with relevant medication. Additional patient-reported measures which can be reported on the patientMpower app include body temperature, activity levels and symptoms.
The control observation will be usual care with a sham electronic application (which will not allow recording of body weight, BP or other measurements).
The objective of this pilot-scale cross-over open label randomized study is to assess the effect of self-monitoring using the patientMpower electronic health journal [+digital weighing scales &BP monitor] on outcomes in ambulatory hemodialysis patients.The primary objective will be to determine the frequency of use of the patientMpower app (+digital weighing scales & BP monitor).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Dublin, Ireland
- Renal Dialysis Centre, Beaumont Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
- Requires maintenance hemodialysis in an ambulatory care setting.
- Aged at least 18 years.
- Has daily unrestricted access to a suitable smart phone or tablet device at home.
- Has an e-mail address.
- Has home broadband and/or mobile data as part of their mobile phone service.
- Demonstrates understanding of correct use of the patientMpower application, digital weighing scales, BP monitor and other study equipment.
- Capable and willing to perform measurements (e.g. weight, BP) at home and record information on the patientMpower application on a daily basis.
- Willing to give written informed consent.
Exclusion Criteria:
- Significant confusion or any concomitant medical condition, which would limit the ability of the patient to record symptoms or other parameters on an electronic health journal
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Sequence 1
Usual care for 2 weeks followed by using patientMpower application [+digital weighing scales & BP monitor] for 4 weeks followed by sham application (without digital scales or BP monitor) for 4 weeks.
|
electronic health journal for patient to record weight, blood pressure, medication adherence and symptoms
dummy application which does not allow recording of weight, blood pressure, medication adherence and symptoms
|
Other: Sequence 2
Usual care for 2 weeks followed by sham application (without digital scales or BP monitor) for 4 weeks followed by using patientMpower application [+digital weighing scales & BP monitor] for 4 weeks.
|
electronic health journal for patient to record weight, blood pressure, medication adherence and symptoms
dummy application which does not allow recording of weight, blood pressure, medication adherence and symptoms
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Engagement With patientMpower App to Record Body Weight
Time Frame: 28 days
|
Actual number of days body weight reported by patient on patientMpower app
|
28 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of patientMpower App [+Digital Scales & BP Monitor] on Ultrafiltration Rate (Proportion </= 10mL/kg/h)
Time Frame: 28 days
|
Proportion of hemodialysis sessions in which ultrafiltration rate is less than/equals 10mL/kg/h
|
28 days
|
Effect of patientMpower App [+Digital Scales & BP Monitor] on Interdialytic Weight Gain (Relative to Dry Weight)
Time Frame: 28 days
|
Average interdialytic weight gain as percentage of patient's dry weight
|
28 days
|
Effect of patientMpower App [+Digital Scales & BP Monitor] on Interdialytic Weight Gain (Absolute)
Time Frame: 28 days
|
Average interdialytic weight gain in kg
|
28 days
|
Effect of patientMpower App [+Digital Scales & BP Monitor] on Interdialytic Weight Gain (Proportion </= 4%)
Time Frame: 28 days
|
Proportion of hemodialysis sessions in which interdialytic weight gain is less than/equals 4%
|
28 days
|
Effect of patientMpower App [+Digital Scales & BP Monitor] on Predialysis Weight
Time Frame: 28 days
|
predialysis weight
|
28 days
|
Effect of patientMpower App [+Digital Scales & BP Monitor] on Pre-dialysis Systolic Blood Pressure
Time Frame: 28 days
|
pre-dialysis supine systolic blood pressure
|
28 days
|
Effect of patientMpower App [+Digital Scales & BP Monitor] on Pre-dialysis Diastolic Blood Pressure
Time Frame: 28 days
|
pre-dialysis supine diastolic blood pressure
|
28 days
|
Patient Engagement With patientMpower App to Record Medication Adherence
Time Frame: 28 days
|
actual number of days medication adherence reported by patient on patientMpower app
|
28 days
|
Patient Engagement With patientMpower App to Record Blood Pressure.
Time Frame: 28 days
|
actual number of days blood pressure reported by patient on patientMpower app
|
28 days
|
Patient Engagement With patientMpower App to Record Symptoms
Time Frame: 28 days
|
Actual number of days symptoms reported by patient on patientMpower application
|
28 days
|
Patient Engagement With patientMpower App to Record Fluid Intake
Time Frame: 28 days
|
Actual number of days fluid intake reported by patients on patientMpower application
|
28 days
|
Effect of patientMpower App [+Digital Scales & BP Monitor] on Requirement for Additional Unscheduled Hemodialysis.
Time Frame: 28 days
|
number of patients requiring additional unscheduled hemodialysis sessions
|
28 days
|
Patient Opinion on Utility and Acceptability of patientMpower Application
Time Frame: 28 days
|
Questionnaire-based assessment: 7 questions. [pMp = patientMpower intervention]
|
28 days
|
Effect of patientMpower App [+Digital Scales & BP Monitor] on Pre-dialysis Inferior Vena Cava Collapsibility
Time Frame: 28 days
|
number of patients with at least 50% collapsibility
|
28 days
|
Effect of patientMpower App [+Digital Scales & BP Monitor] on Pre-dialysis Inferior Vena Cava Longitudinal Diameter
Time Frame: 28 days
|
longitudinal diameter
|
28 days
|
Effect of patientMpower App [+Digital Scales & BP Monitor] on Pre-dialysis Inferior Vena Cava Transverse Diameter
Time Frame: 28 days
|
transverse diameter
|
28 days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Renal Dialysis Centre, Beaumont Hospital, Dublin 9, Ireland
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Hemodialysis patientMpower02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Renal Dialysis
-
Trakya UniversityCompleted
-
University of PittsburghNational Institute of Nursing Research (NINR); University of IowaCompleted
-
Inje UniversityKorea University Guro Hospital; Seoul National University; Hallym University... and other collaboratorsCompleted
-
Universidad Miguel Hernandez de ElcheCompleted
-
National University Hospital, SingaporeNational University of SingaporeUnknown
-
Far Eastern Memorial HospitalUnknown
-
Hamamatsu UniversityMaruyama Memorial General Hospital; Seirei Hamamatsu General Hospital; Iwata... and other collaboratorsTerminated
-
Hamamatsu UniversityMaruyama Memorial General Hospital; Seirei Hamamatsu General Hospital; Iwata... and other collaboratorsCompleted
-
The First Affiliated Hospital of Zhejiang Chinese...Not yet recruiting
-
Rabin Medical CenterNot yet recruitingRenal Dialysis
Clinical Trials on patientMpower application
-
Imperial College Healthcare NHS TrustImperial College London; University College, London; patientMpower Ltd.; Action...RecruitingInterstitial Lung DiseaseUnited Kingdom
-
patientMpower Ltd.Health Service Executive, IrelandCompletedIdiopathic Pulmonary FibrosisIreland
-
Universidad Católica San Antonio de MurciaNot yet recruitingPhysical Activity | Adolescent Behavior | New Technologies
-
Johns Hopkins UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Vanderbilt... and other collaboratorsActive, not recruitingNephrectomy | Kidney | Living DonorsUnited States
-
Assiut UniversityCompletedImproving Quality of LifeEgypt
-
Ataturk Training and Research HospitalNot yet recruiting
-
TC Erciyes UniversityCompleted
-
University of North Carolina, Chapel HillCompleted
-
The University of Hong KongCompletedEarly Childhood CariesHong Kong